285 related articles for article (PubMed ID: 32885475)
21. Correction of Malocclusion by Botulinum Neurotoxin Injection into Masticatory Muscles.
Seok H; Kim SG
Toxins (Basel); 2018 Jan; 10(1):. PubMed ID: 29301317
[TBL] [Abstract][Full Text] [Related]
22. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
Cardoso F
Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
[TBL] [Abstract][Full Text] [Related]
23. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
Zhang LD; Liu Q; Zou DR; Yu LF
Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin in the management of myalgia in temporomandibular disorders: are all injections equal?
Anwar H; Attard A; Green J; Elledge ROC
Br J Oral Maxillofac Surg; 2023 Jan; 61(1):89-93. PubMed ID: 36522255
[TBL] [Abstract][Full Text] [Related]
25. RimabotulinumtoxinB versus OnabotulinumtoxinA in the treatment of masseter hypertrophy: a 24-week double-blind randomized split-face study.
Lee DH; Jin SP; Cho S; Feneran A; Youn CS; Won CH; Park GH; Kim BW; An J; Chang SE; Lee MW
Dermatology; 2013; 226(3):227-32. PubMed ID: 23774030
[TBL] [Abstract][Full Text] [Related]
26. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?
Delcanho R; Val M; Guarda Nardini L; Manfredini D
J Oral Facial Pain Headache; 2022; 36(1):6-20. PubMed ID: 35298571
[TBL] [Abstract][Full Text] [Related]
27. Botulinum Toxin Type A for Painful Temporomandibular Disorders: Systematic Review and Meta-Analysis.
Machado D; Martimbianco ALC; Bussadori SK; Pacheco RL; Riera R; Santos EM
J Pain; 2020; 21(3-4):281-293. PubMed ID: 31513934
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
[TBL] [Abstract][Full Text] [Related]
29. Unclear results for the use of botulinum toxin therapy for TMD pain.
Keenan JR
Evid Based Dent; 2015 Dec; 16(4):122. PubMed ID: 26680526
[TBL] [Abstract][Full Text] [Related]
30. Cerebral palsy and bruxism: Effects of botulinum toxin injections-A randomized controlled trial.
Cahlin BJ; Lindberg C; Dahlström L
Clin Exp Dent Res; 2019 Oct; 5(5):460-468. PubMed ID: 31687178
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin in the management of temporomandibular disorders: a systematic review.
Thambar S; Kulkarni S; Armstrong S; Nikolarakos D
Br J Oral Maxillofac Surg; 2020 Jun; 58(5):508-519. PubMed ID: 32143934
[TBL] [Abstract][Full Text] [Related]
32. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
Porta M
Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
[TBL] [Abstract][Full Text] [Related]
34. Botulinum Toxin Versus Dextrose Prolotherapy: Which is More Effective for Temporomandibular Joint Subluxation? A Randomized Clinical Trial.
Cömert Kiliç S; Kiliç N; Güngörmüş M
J Oral Maxillofac Surg; 2023 Apr; 81(4):389-395. PubMed ID: 36693543
[TBL] [Abstract][Full Text] [Related]
35. Mandibular Bone Loss after Masticatory Muscles Intervention with Botulinum Toxin: An Approach from Basic Research to Clinical Findings.
Balanta-Melo J; Toro-Ibacache V; Kupczik K; Buvinic S
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30717172
[TBL] [Abstract][Full Text] [Related]
36. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Yoshida K
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
[TBL] [Abstract][Full Text] [Related]
37. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
von Lindern JJ; Niederhagen B; Bergé S; Appel T
J Oral Maxillofac Surg; 2003 Jul; 61(7):774-8. PubMed ID: 12856249
[TBL] [Abstract][Full Text] [Related]
38. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
Sidebottom AJ; Patel AA; Amin J
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the Efficacy of Botulinum Toxin, Local Anesthesia, and Platelet-Rich Plasma Injections in Patients With Myofascial Trigger Points in the Masseter Muscle.
Yilmaz O; Sivrikaya EC; Taskesen F; Pirpir C; Ciftci S
J Oral Maxillofac Surg; 2021 Jan; 79(1):88.e1-88.e9. PubMed ID: 33045182
[TBL] [Abstract][Full Text] [Related]
40. Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.
Li K; Tan K; Yacovelli A; Bi WG
J Oral Rehabil; 2024 May; 51(5):886-897. PubMed ID: 38151884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
